Mylan Receives FDA Approval For Generic Version Of Viramune Tablets - NASDAQ

(RTTNews.com) - Mylan Inc. (MYL) announced Wednesday that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration or FDA for its Abbreviated New Drug Application or ANDA for Nevirapine ...

More Generic Launches for Mylan - Analyst Blog - NASDAQ

Mylan Pharmaceuticals Inc., a subsidiary of generic pharma major Mylan Inc. ( MYL), recently announced that it has received final approval from the U.S. Food & Drug Administration (FDA) for its generic version of Boehringer Ingelheim's Viramune (nevirapine).

Aurobindo Pharma Gets Final Nod For Nevirapine Tablets And Oral Suspension - RTT News

Nevirapine tablets 200 mg and Oral Suspension 50mg/5mL are the generic equivalent of Boehringer Ingelheim Pharmaceutical Inc.'s Viramune tablets 200 mg and Oral Suspension 50mg/5mL. The products are indicated as part of antiretroviral combination therapy ...

More Generic Launches for Mylan - Yahoo Finance

Viramune is approved for HIV-1 infection in combination with antiretroviral (:ARV) treatment. According to IMS Health, Viramune generated U.S. revenues of approximately $116.6 million for the 12 months ending March 31, 2012. Apart from Mylan ...

Mylan Launches Generic Viramune Tablets - Monthly Prescribing Reference

Mylan announced the launch of Nevirapine tablets 200mg, the generic version of Boehringer Ingelheim's Viramune tablets 200mg. Viramune is a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for combination antiretroviral treatment of HIV-1 ...

FDA OKs Aurobindo's generic of Boehringer's HIV drug Viramune - SmartBrief

Want to see more news summaries? Sign up for AHIP Solutions SmartBrief AHIP Solutions SmartBrief is a FREE, daily email newsletter that summarizes the day's top industry news from hundreds of sources. Each day, subscribers receive 8-10 headlines and news ...

Aurobindo gets US FDA nod for nevirapine tabs & oral suspension - pharmabiz.com

Nevirapine tablets and oral suspension are the generic equivalent of Boehringer Ingelheim Pharmaceutical Inc's Viramune tablets 200mg and oral suspension 50mg/5mL. The products are indicated as part of anti retroviral (ARV) combination therapy for the ...

Mylan launches HIV-drug Nevirapine in US - pharmabiz.com

This product is the generic version of Boehringer Ingelheim's Viramune and is indicated for combination antiretroviral (ARV) treatment of HIV-1 infection. Mylan CEO Heather Bresch said: "The launch of Nevirapine tablets, 200 mg, in the US further expands ...

China Biotech In Review: Surgical Instrument Acquisition Takes Mindray Into New Territory - Seekingalpha.com

Breckenridge will market Nevirapine, a generic version of Boehringer Ingelheim's antiviral HIV drug, Viramune, in the US after BI's patent on Viramune expires on May 22, 2012. Trials and Approvals Shanghai Generon will initiate a randomized, multi-center ...

Aurobindo gets approval from US FDA for Neviraping tablets - New Kerala

Nevirapine Tablets 200mg and Oral Suspension 50mg/5mL are the generic equivalent of Boehringer Ingelheim Pharmaceutical Inc's Viramune Tablets 200mg and Oral Suspension 50mg/5mL. The products are indicated as part of antiretroviral (ARV) combination ...